{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:39:41Z","timestamp":1778931581111,"version":"3.51.4"},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Bras. Nefrol."],"abstract":"<jats:p>ABSTRACT  Introduction: Fabry disease (FD) is a disorder caused by mutations in the gene encoding for lysosomal enzyme \u03b1-galactosidase A (\u03b1-GAL). Reduced \u03b1-GAL activity leads to progressive accumulation of globotriaosylceramide (Gb3), also known as CD77. The recent report of increased expression of CD77 in blood cells of patients with FD indicated that this molecule can be used as a potential marker for monitoring enzyme replacement therapy (ERT).  Objective: The purpose of this study was to evaluate the CD77 levels throughout ERT in FD patients (V269M mutation).  Methods: We evaluated the fluctuations in PBMC (peripheral blood mononuclear cell) membrane CD77 expression in FD patients undergoing ERT and correlated these levels with those observed in different cell types.  Results: A greater CD77 expression was found in phagocytes of patients compared to controls at baseline. Interestingly, the variability in CD77 levels is larger in patients at baseline (340 - 1619 MIF) and after 12 months of ERT (240 - 530 MIF) compared with the control group (131 - 331 MFI). Furthermore, by analyzing the levels of CD77 in phagocytes from patients throughout ERT, we found a constant decrease in CD77 levels.  Conclusion: The increased CD77 levels in the phagocytes of Fabry carriers together with the decrease in CD77 levels throughout ERT suggest that measuring CD77 levels in phagocytes is a promising tool for monitoring the response to ERT in FD.<\/jats:p>","DOI":"10.1590\/2175-8239-jbn-3910","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T08:47:07Z","timestamp":1528274827000},"page":"333-338","source":"Crossref","is-referenced-by-count":3,"title":["CD77 levels over enzyme replacement treatment in Fabry Disease Family (V269M)"],"prefix":"10.1590","volume":"40","author":[{"given":"Ester Miranda","family":"Pereira","sequence":"first","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalberto Socorro da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimundo Nonato da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Tiburcio","family":"Monte Neto","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando F. do","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackeline L. M.","family":"Sousa","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique C\u00e9sar Saraiva de Ar\u00eaa Le\u00e3o","family":"Costa Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herton Luiz Alves","family":"Sales Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatalia","family":"Labilloy","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semiramis Jamil Hadad do","family":"Monte","sequence":"additional","affiliation":[{"name":"Universidade Federal do Piau\u00ed,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2018,12]]},"reference":[{"key":"ref1","first-page":"325","article-title":"The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus","volume":"17","author":"Opitz JM","year":"1965","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry's disease: alpha-galactosidase deficiency","volume":"167","author":"Kint JA","year":"1970","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000369307","article-title":"When foots come first: early signs of podocyte injury in Fabry nephropathy without proteinuria","volume":"129","author":"Becherucci F","year":"2015","journal-title":"Nephron"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease.","volume":"5","author":"Germain DP","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart A","year":"2007","journal-title":"Heart"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld EF","year":"1991","journal-title":"Annu Rev Biochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot KD","year":"2001","journal-title":"J Med Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman AH","year":"2004","journal-title":"Nature Rev Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts JM","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta S","year":"2005","journal-title":"Medicine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot KD","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbadis.2010.05.003","article-title":"Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"Rombach SM","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/08035320510028111","article-title":"Is globotriaosylceramide a useful biomarker in Fabry disease?","volume":"94","author":"Young E","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.2008.576","article-title":"Downregulation of alpha-galactosidase A upregulates CD77: functional impact for Fabry nephropathy","volume":"75","author":"Thomaidis T","year":"2009","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref16","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten M","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830210507","article-title":"CD77: an antigen of germinal center B cells entering apoptosis","volume":"21","author":"Mangeney M","year":"1991","journal-title":"Eur J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/349612a0","article-title":"Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis","volume":"349","author":"Gregory CD","year":"1991","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(83)90601-3","article-title":"Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis","volume":"2","author":"O'Brien AD","year":"1983","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","article-title":"Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool","volume":"7","author":"Falgui\u00e8res T","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","article-title":"The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer","volume":"102","author":"Kovbasnjuk O","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/rcm.728","article-title":"Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease","volume":"16","author":"Boscaro F","year":"2002","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["Brazilian Journal of Nephrology"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbn\/v40n4\/2175-8239-jbn-3910.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T13:19:00Z","timestamp":1579871940000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0101-28002018000400333&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["S0101-28002018000400333"],"URL":"https:\/\/doi.org\/10.1590\/2175-8239-jbn-3910","relation":{},"ISSN":["2175-8239","0101-2800"],"issn-type":[{"value":"2175-8239","type":"electronic"},{"value":"0101-2800","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}